NM Vashist, M Samaan, MH Mosli… - The Cochrane …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Endoscopic assessment of mucosal disease activity is routinely used to determine eligibility and response to therapy in clinical trials of ulcerative colitis. The …
M Samaan, MH Mosli, CE Parker… - The Cochrane …, 2018 - europepmc.org
Background Endoscopic assessment of mucosal disease activity is routinely used to determine eligibility and response to therapy in clinical trials of ulcerative colitis. The …
Background: Endoscopic assessment of mucosal disease activity is routinely used to determine eligibility and response to therapy in clinical trials of ulcerative colitis. The …
NM Vashist, M Samaan, MH Mosli… - The Cochrane …, 2018 - ncbi.nlm.nih.gov
Background Endoscopic assessment of mucosal disease activity is routinely used to determine eligibility and response to therapy in clinical trials of ulcerative colitis. The …
N Mohammed Vashist, M Samaan… - Cochrane Database …, 1996 - cochranelibrary.com
Background Endoscopic assessment of mucosal disease activity is routinely used to determine eligibility and response to therapy in clinical trials of ulcerative colitis. The …
N Mohammed Vashist, M Samaan… - status and date: New …, 2018 - researchgate.net
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis (Review) Page 1 Cochrane Database of Systematic Reviews Endoscopic scoring indices for evaluation …
M Mosli, M Samaan, SA Nelson… - Cochrane Database …, 2015 - ksascholar.dri.sa
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to systematically review the current literature describing the …